S. Demir Et Al. , "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.," Clinical and experimental rheumatology , vol.38, no.3, pp.552-557, 2020
Demir, S. Et Al. 2020. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.. Clinical and experimental rheumatology , vol.38, no.3 , 552-557.
Demir, S., Soyer, Ö., Bilginer, Y., Sag, E., Sahiner, Ü. M., Buyuktiryaki, B., ... Sekerel, B. E.(2020). Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.. Clinical and experimental rheumatology , vol.38, no.3, 552-557.
Demir, S Et Al. "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.," Clinical and experimental rheumatology , vol.38, no.3, 552-557, 2020
Demir, S Et Al. "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.." Clinical and experimental rheumatology , vol.38, no.3, pp.552-557, 2020
Demir, S. Et Al. (2020) . "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.." Clinical and experimental rheumatology , vol.38, no.3, pp.552-557.
@article{article, author={S Demir Et Al. }, title={Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.}, journal={Clinical and experimental rheumatology}, year=2020, pages={552-557} }